Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5769)
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
18,706
Price
$6.01
Total Value
$112.39K
Shares Held After
633,867
% of Holdings
2.9%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
16,696
Price
$6.01
Total Value
$100.31K
Shares Held After
565,592
% of Holdings
2.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
969
Price
$72.90
Total Value
$70.64K
Shares Held After
105,272
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,844
Price
$72.39
Total Value
$133.49K
Shares Held After
106,241
% of Holdings
1.7%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
77
Price
$390.67
Total Value
$30.08K
Shares Held After
1,189
% of Holdings
6.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$26.18
Total Value
$123.83K
Shares Held After
36,475
% of Holdings
11.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,100
Price
$59.35
Total Value
$65.28K
Shares Held After
25,000
% of Holdings
4.2%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
3,900
Price
$58.37
Total Value
$227.65K
Shares Held After
26,100
% of Holdings
13.0%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
3,749
Price
$19.94
Total Value
$74.76K
Shares Held After
39,900
% of Holdings
8.6%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
37,945
Price
$19.85
Total Value
$753.33K
Shares Held After
43,649
% of Holdings
46.5%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.27
Total Value
$10.27K
Shares Held After
19,592
% of Holdings
5.1%
Sotera Health Co (SHC)
Petras Michael B. Jr. — Director
Shares
850,000
Price
$18.50
Total Value
$15.73M
Shares Held After
3,969,393
% of Holdings
17.6%
Sotera Health Co (SHC)
Petras Michael B. Jr. — Director
Shares
294,515
Price
$18.50
Total Value
$5.45M
Shares Held After
397,912
% of Holdings
42.5%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
500
Price
$64.16
Total Value
$32.08K
Shares Held After
61,500
% of Holdings
0.8%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
2,600
Price
$63.50
Total Value
$165.10K
Shares Held After
62,000
% of Holdings
4.0%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
1,900
Price
$62.53
Total Value
$118.80K
Shares Held After
64,600
% of Holdings
2.9%
INSMED Inc (INSM)
SHAROKY MELVIN MD — Director
Shares
5,000
Price
$127.53
Total Value
$637.65K
Shares Held After
0
% of Holdings
100.0%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
1,730
Price
$29.59
Total Value
$51.19K
Shares Held After
75,964
% of Holdings
2.2%
TELA Bio, Inc. (TELA)
Getz Heather C — Director
Shares
12,500
Price
$0.66
Total Value
$8.31K
Shares Held After
532,500
% of Holdings
2.3%
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$12.00
Total Value
$84.00K
Shares Held After
76,865
% of Holdings
8.3%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,388
Price
$59.35
Total Value
$82.38K
Shares Held After
40,036
% of Holdings
3.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
4,630
Price
$58.35
Total Value
$270.17K
Shares Held After
41,424
% of Holdings
10.1%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,000
Price
$20.00
Total Value
$20.00K
Shares Held After
51,776
% of Holdings
1.9%
Aclarion, Inc. (ACON)
Williams Amanda M — Director
Shares
5,857
Price
$2.73
Total Value
$15.99K
Shares Held After
25,857
% of Holdings
22.7%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
284,707
Price
$36.25
Total Value
$10.32M
Shares Held After
18,630,739
% of Holdings
1.5%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
37,256
Price
$0.72
Total Value
$26.90K
Shares Held After
314,480
% of Holdings
10.6%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
187,362
% of Holdings
10.7%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
197,362
% of Holdings
10.2%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
20,679
Price
$0.72
Total Value
$14.93K
Shares Held After
195,808
% of Holdings
9.6%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
187,362
% of Holdings
10.7%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — President&CEO
Shares
26,911
Price
$1.13
Total Value
$30.41K
Shares Held After
2,705,853
% of Holdings
1.0%
Outset Medical, Inc. (OM)
Trigg Leslie — Director
Shares
3,437
Price
$4.39
Total Value
$15.09K
Shares Held After
194,597
% of Holdings
1.7%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
15,000
Price
$27.48
Total Value
$412.18K
Shares Held After
460,215
% of Holdings
3.2%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
11,888
Price
$79.84
Total Value
$949.16K
Shares Held After
226,064
% of Holdings
5.0%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
12,712
Price
$79.20
Total Value
$1.01M
Shares Held After
237,952
% of Holdings
5.1%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
8,400
Price
$78.11
Total Value
$656.09K
Shares Held After
250,664
% of Holdings
3.2%
GILEAD SCIENCES, INC. (GILD)
Dickinson Andrew D — Chief Financial Officer
Shares
3,000
Price
$138.36
Total Value
$415.08K
Shares Held After
165,646
% of Holdings
1.8%
Outset Medical, Inc. (OM)
Brottem John L. — General Counsel
Shares
2,632
Price
$4.39
Total Value
$11.55K
Shares Held After
87,475
% of Holdings
2.9%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm&Corp Aff Officer
Shares
11,470
Price
$138.04
Total Value
$1.58M
Shares Held After
118,234
% of Holdings
8.8%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm&Corp Aff Officer
Shares
16,530
Price
$137.37
Total Value
$2.27M
Shares Held After
129,704
% of Holdings
11.3%
JOHNSON&JOHNSON (JNJ)
Taubert Jennifer L — EVP, WWC. Innovative Medicine
Shares
15,000
Price
$263.36
Total Value
$3.95M
Shares Held After
194,451
% of Holdings
7.2%
Outset Medical, Inc. (OM)
Gaeta Renee — Chief Financial Officer
Shares
4,543
Price
$4.39
Total Value
$19.94K
Shares Held After
180,840
% of Holdings
2.5%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
116
Price
$156.45
Total Value
$18.15K
Shares Held After
11,316
% of Holdings
1.0%
Pacira BioSciences, Inc. (PCRX)
SLONIN JONATHAN — Chief Medical Officer
Shares
3,040
Price
$23.23
Total Value
$70.62K
Shares Held After
216,384
% of Holdings
1.4%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — EVP and Chief Legal Officer
Shares
82
Price
$4.55
Total Value
$373.10
Shares Held After
8,117
% of Holdings
1.0%
OMNICELL, INC. (OMCL)
Njoku Nnamdi — President&COO
Shares
3,083
Price
$36.85
Total Value
$113.61K
Shares Held After
161,224
% of Holdings
1.9%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — EVP, Chief Operating Officer
Shares
64
Price
$4.55
Total Value
$291.20
Shares Held After
8,679
% of Holdings
0.7%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Wong Shelly — SVP, FINANCE AND CAO
Shares
573
Price
$1.93
Total Value
$1.11K
Shares Held After
87,828
% of Holdings
0.6%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Lettmann Jason — Director
Shares
2,230
Price
$1.93
Total Value
$4.30K
Shares Held After
294,379
% of Holdings
0.8%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
1,973
Price
$18.63
Total Value
$36.75K
Shares Held After
493,900
% of Holdings
0.4%
Showing 1–50 of 5769 transactions (page 1 of 116)